Clinical Trial Update: Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of RPH-104 on systemic inflammation, clinical outcomes, and safety in patients with ST-segment elevation myocardial infarcti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• RPH-104

Snippet

Sponsor: R-Pharm Overseas, Inc. | Conditions: Acute ST Segment Elevation Myocardial Infarction | Phase 2 | Status: COMPLETED | Results posted: 2024-01-24